1.
Rouanet J, Joulie I, Lambert C, D’Incan M. Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses. Acta Derm Venereol [Internet]. 2022 Jul. 7 [cited 2022 Sep. 26];102:adv00746. Available from: https://medicaljournalssweden.se/actadv/article/view/718